Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Bombardier and Rolls-Royce Elevate Aircraft Health Monitoring for New and In-Service Global 5500 and 6500 Aircraft, Upgrade Now Available Across Bombardier’s Service Centre Network
-
OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms
-
New final terms for Euro Medium Term Note Programme - Nykredit Realkredit A/S
-
NuCube Energy to Become a Publicly Listed Company Through Business Combination with Launch Two Acquisition Corp.
-
Digital Currency X Technology Enters Into Securities Purchase Agreement for a Private Placement of US$700 Million of Units, Payable in U.S. Dollars or Digital Assets, to Advance Its Digital Asset Trea
-
Storaktionærmeddelelse
-
Flash Sports & Media (Nasdaq: FLZH) Announces Planned Launch of Zimbabwe T20 League (ZT20)
-
Flash Sports & Media (Nasdaq: FLZH) Announces Planned Launch of Zimbabwe T20 League (ZT20)
-
Spectral Medical Announces U.S. FDA Filing of PMA Application for PMX
-
NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navigation System
-
Kymera Therapeutics Completes Enrollment in the Phase 2b BROADEN2 Trial of KT-621 in Atopic Dermatitis with Topline Data by Year-end 2026
-
Xali Gold Discovers Higher Grade Gold Mineralization at Pico Machay
-
Argo and Town of Caledon Announce Fall Smart Routing™ Launch
-
Impact Analytics Research Identifies Holiday 2026's Defining Promotional Strategy: Broader Reach, Disciplined Depth
-
Purpose Investments Inc. Announces Final June 2026 Distribution Rate for Purpose High Interest Savings Fund, Purpose US Cash Fund, Purpose Cash Management Fund, and Purpose USD Cash Management Fund
-
NexGold Intersects 61.22 g/t Gold over 12.0 Metres and 5.85 g/t Gold over 13.0 Metres During Infill Drill Program at the Goldboro Gold Project in Nova Scotia
-
Atea Pharmaceuticals Completes Patient Enrollment in Phase 3 C-FORWARD Trial Evaluating Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus
-
Asante Provides Strategic Review and Operational Update
-
Seres Therapeutics to Host Webcast on July 8, 2026, to Discuss Results of Investigator-Sponsored Trial of Seres’ SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis
-
Initial Lightbridge Fuel™ Material Samples Removed from Idaho National Laboratory’s Advanced Test Reactor
-
NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navigation System
-
Tiziana Announces Last Patient Successfully Dosed in its Phase 2 INFORM-MS Trial
-
GDS Concludes Successful 2026 Annual General Meeting with All Resolutions Passed, Including Election and Re-election of Directors
-
Calgon Carbon Wins AWWA Innovation Award for PFAS Destruction Breakthrough
-
Troilus Drills 157.5 Metres Grading 0.95 g/t AuEq While Targeting Inferred Material Within the Z87 Reserve Pit
-
Montauk Brewing Kicks Off Summer with 14th Anniversary Celebration, Limited Brew Barn Release and Beach Cleanup
-
Highlander Silver: Comprehensive Geophysical Program Maps Extensive System Concealed by Shallow Cover at Corani
-
Impact Analytics Research Identifies Holiday 2026's Defining Promotional Strategy: Broader Reach, Disciplined Depth
-
INmune Bio Inc. Achieves MHRA Approval of PIP for CORDStrom™
-
Winnebago Industries Reports Third Quarter Fiscal 2026 Results
-
Verano to Report Second Quarter 2026 Financial Results on August 5, 2026
-
Lithium Ionic Advances Construction Readiness at Bandeira; Secures Construction-Phase Water Access and Provides Engineering and Procurement Updates
-
Baker Hughes to Deliver Subsea Production Systems to Support Azule Energy’s Greater PAJ Development
-
Satellos to Present Clinical Program Updates at ICNMD 2026
-
Autolus Therapeutics to Participate in Upcoming Investor Conference
-
Manhattan Bridge Capital, Inc. Announces Payment of Quarterly Dividend
-
Herantis appoints experienced drug development expert Dr Juha Savola as Chief Medical Officer
-
AnaCardio´s Phase 1b/2a GOAL-HF1 study in patients with Heart Failure and Reduced Ejection Fraction (HFrEF) published in The Lancet
-
Fixing of coupon rate effective from 1 July 2026
-
Treno Scope Launches “Data for All” Initiative, Empowering Developers in Vietnam and Thailand
-
Fixing of Coupon Interest Rate
-
Nyrstar NV - Publication of legal opinion
-
Fixing of coupon rates - Nykredit Realkredit A/S
-
Leads Biolabs Announces Partner Oblenio Bio’s $62 Million Oversubscribed Series B Financing to Advance Tri-Specific T-Cell Engager LBL‑051 for Autoimmune Diseases into Clinical Development
-
ProQR Prices $50.0 Million Underwritten Registered Direct Offering and Concurrent Private Placement
-
Dimensional Fund Advisors Ltd. : Form 8.3 - SPIRE HEALTHCARE GROUP PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - SEGRO PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - PROLOGIS INC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - PICTON PROPERTY INCOME LTD - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - PHAROS ENERGY PLC - Ordinary Shares
